2 results
A 16-Week Open-Label Study of the Effects of Treatment With Pimavanserin on Activities of Daily Living in Subjects With Parkinson’s Disease Psychosis
-
- Journal:
- CNS Spectrums / Volume 28 / Issue 2 / April 2023
- Published online by Cambridge University Press:
- 14 April 2023, p. 239
-
- Article
-
- You have access
- Export citation
158 Open-label Study of Pimavanserin Patients with Comorbid Parkinson’s Disease and Depression
-
- Journal:
- CNS Spectrums / Volume 25 / Issue 2 / April 2020
- Published online by Cambridge University Press:
- 24 April 2020, p. 301
-
- Article
-
- You have access
- Export citation